bpc-157 intestinal permeability tight junction study as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers Epithelial barrier function in gut-bone
Description
In animal studies it is administered once daily subcutaneously, intraperitoneally or orally (gastric-stable)
B12 deficiency symptoms Sore mouth and tongue, numbness and tingling in the legs, poor dental health and bleeding gums, memory loss, anaemia, exhaustion, mood changes, depression & anxiety, breathlessness, insomnia, vertigo, brittle nails
Are taking anticoagulants or corticosteroids
Contains bacteriostatic agent (benzyl alcohol 0.9%)
Allow it to air dry for ten seconds
However, no human safety data from controlled clinical trials currently exists
